Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Immunology and Infection / Assays for the Identification of Novel Antivirals …
JoVE Journal
Immunology and Infection

A subscription to JoVE is required to view this content. Sign in or start your free trial.

JoVE Journal Immunology and Infection
Assays for the Identification of Novel Antivirals against Bluetongue Virus
 

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Article DOI: 10.3791/50820-v • 12:02 min • October 11th, 2013
October 11th, 2013 •
1, 2, 1
1Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, 2Molette Laboratory for Drug Discovery, Department of Chemistry and Biochemistry, Auburn University

Chapters

Summary
Automatic Translation

Three assays, including the cytopathic effect (CPE)-based assay, dose-response assay and Time-of-Addition (ToA) assay have been developed, optimized, validated and utilized to identify novel antivirals against Bluetongue virus (BTV), as well as to determine the possible Mechanism-of-Action (MoA) for newly identified antivirals.

Tags

Antiviral Assays BTV Antivirals Cytopathic Effect (CPE) Assay Dose-response Assay Mechanism Of Action (ToA) Assay Antiviral Screening Viral Lifecycle Cell Culture System
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter